Table 3.

Sensitivity analysis summary (I² = 0%).

Meta-Analysis	Outcome	Removed Studies	Results
Primary Analysis	MACEs	[20,21]	OR 1.02, 95% CI 0.94–1.11, p = 0.62
	TVR	[19]	OR 1.42, 95% CI 1.22–1.65, p < 0.01
	CVD	[21]	OR 1.00, 95% CI 0.89–1.11, p = 0.95
	ACD	[21]	OR 1.04, 95% CI 0.93–1.16, p = 0.45
Clopidogrel Analysis	MACEs	[15,19]	OR 1.45, 95% CI 1.31–1.60, p < 0.001
	MI	[21]	OR 0.89, 95% CI 0.72–1.11, p = 0.29
	TVR	[19]	OR 1.42, 95% CI 1.22–1.65, p < 0.001
	CVD	[15]	OR 1.42, 95% CI 1.09–1.84, p = 0.008

MACEs, major adverse cardiovascular events; MI, myocardial infarction; TVR, target vessel revascularization; CVD, cardiovascular death; ACD, all cause death.